LIN37 Antikörper
-
- Target Alle LIN37 Antikörper anzeigen
- LIN37 (Lin-37 Homolog (LIN37))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LIN37 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purified
- Immunogen
- LIN37 antibody was raised using a synthetic peptide corresponding to a region with amino acids HQRRKKRREMDDGLAEGGPQRSNTYVIKLFDRSVDLAQFSENTPLYPICR
- Top Product
- Discover our top product LIN37 Primärantikörper
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
LIN37 Blocking Peptide, catalog no. 33R-3828, is also available for use as a blocking control in assays to test for specificity of this LIN37 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LIN37 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- LIN37 (Lin-37 Homolog (LIN37))
- Andere Bezeichnung
- LIN37 (LIN37 Produkte)
- Synonyme
- F25965 antikoerper, ZK418.4 antikoerper, lin-37 antikoerper, 1810054G18Rik antikoerper, lin-37 DREAM MuvB core complex component antikoerper, lin-37 homolog (C. elegans) antikoerper, LIN37 antikoerper, Lin37 antikoerper
- Hintergrund
- This gene encodes a protein expressed in the eye.
- Molekulargewicht
- 28 kDa (MW of target protein)
- Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
-